Cargando…

Prospects of Probiotic Adjuvant Drugs in Clinical Treatment

In modern society, where new diseases and viruses are constantly emerging, drugs are still the most important means of resistance. However, adverse effects and diminished efficacy remain the leading cause of treatment failure and a major determinant of impaired health-related quality of life for pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Zhongyue, Hong, Yan, Huo, Yalan, Peng, Lingling, Lv, Huihui, Chen, Jiahui, Wu, Zhihua, Wan, Cuixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697729/
https://www.ncbi.nlm.nih.gov/pubmed/36432410
http://dx.doi.org/10.3390/nu14224723
_version_ 1784838639417556992
author Ren, Zhongyue
Hong, Yan
Huo, Yalan
Peng, Lingling
Lv, Huihui
Chen, Jiahui
Wu, Zhihua
Wan, Cuixiang
author_facet Ren, Zhongyue
Hong, Yan
Huo, Yalan
Peng, Lingling
Lv, Huihui
Chen, Jiahui
Wu, Zhihua
Wan, Cuixiang
author_sort Ren, Zhongyue
collection PubMed
description In modern society, where new diseases and viruses are constantly emerging, drugs are still the most important means of resistance. However, adverse effects and diminished efficacy remain the leading cause of treatment failure and a major determinant of impaired health-related quality of life for patients. Clinical studies have shown that the disturbance of the gut microbial structure plays a crucial role in the toxic and side effects of drugs. It is well known that probiotics have the ability to maintain the balance of intestinal microecology, which implies their potential as an adjunct to prevent and alleviate the adverse reactions of drugs and to make medicines play a better role. In addition, in the past decade, probiotics have been found to have excellent prevention and alleviation effects in drug toxicity side effects, such as liver injury. In this review, we summarize the development history of probiotics, discuss the impact on drug side effects of probiotics, and propose the underlying mechanisms. Probiotics will be a new star in the world of complementary medicine.
format Online
Article
Text
id pubmed-9697729
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96977292022-11-26 Prospects of Probiotic Adjuvant Drugs in Clinical Treatment Ren, Zhongyue Hong, Yan Huo, Yalan Peng, Lingling Lv, Huihui Chen, Jiahui Wu, Zhihua Wan, Cuixiang Nutrients Review In modern society, where new diseases and viruses are constantly emerging, drugs are still the most important means of resistance. However, adverse effects and diminished efficacy remain the leading cause of treatment failure and a major determinant of impaired health-related quality of life for patients. Clinical studies have shown that the disturbance of the gut microbial structure plays a crucial role in the toxic and side effects of drugs. It is well known that probiotics have the ability to maintain the balance of intestinal microecology, which implies their potential as an adjunct to prevent and alleviate the adverse reactions of drugs and to make medicines play a better role. In addition, in the past decade, probiotics have been found to have excellent prevention and alleviation effects in drug toxicity side effects, such as liver injury. In this review, we summarize the development history of probiotics, discuss the impact on drug side effects of probiotics, and propose the underlying mechanisms. Probiotics will be a new star in the world of complementary medicine. MDPI 2022-11-09 /pmc/articles/PMC9697729/ /pubmed/36432410 http://dx.doi.org/10.3390/nu14224723 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ren, Zhongyue
Hong, Yan
Huo, Yalan
Peng, Lingling
Lv, Huihui
Chen, Jiahui
Wu, Zhihua
Wan, Cuixiang
Prospects of Probiotic Adjuvant Drugs in Clinical Treatment
title Prospects of Probiotic Adjuvant Drugs in Clinical Treatment
title_full Prospects of Probiotic Adjuvant Drugs in Clinical Treatment
title_fullStr Prospects of Probiotic Adjuvant Drugs in Clinical Treatment
title_full_unstemmed Prospects of Probiotic Adjuvant Drugs in Clinical Treatment
title_short Prospects of Probiotic Adjuvant Drugs in Clinical Treatment
title_sort prospects of probiotic adjuvant drugs in clinical treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697729/
https://www.ncbi.nlm.nih.gov/pubmed/36432410
http://dx.doi.org/10.3390/nu14224723
work_keys_str_mv AT renzhongyue prospectsofprobioticadjuvantdrugsinclinicaltreatment
AT hongyan prospectsofprobioticadjuvantdrugsinclinicaltreatment
AT huoyalan prospectsofprobioticadjuvantdrugsinclinicaltreatment
AT penglingling prospectsofprobioticadjuvantdrugsinclinicaltreatment
AT lvhuihui prospectsofprobioticadjuvantdrugsinclinicaltreatment
AT chenjiahui prospectsofprobioticadjuvantdrugsinclinicaltreatment
AT wuzhihua prospectsofprobioticadjuvantdrugsinclinicaltreatment
AT wancuixiang prospectsofprobioticadjuvantdrugsinclinicaltreatment